Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maria Souggleri"'
Real-World Data on Thromboprophylaxis in Active Cancer Patients: Where Are We? Are We Getting There?
Autor:
Nikolaos Tsoukalas, Pavlos Papakotoulas, Athina Christopoulou, Alexandros Ardavanis, Georgios Koumakis, Christos Papandreou, Georgios Papatsimpas, Pavlos Papakostas, Georgios Samelis, Charalambos Andreadis, Gerasimos Aravantinos, Nikolaos Ziras, Charalambos Kalofonos, Epameinondas Samantas, Maria Souggleri, Paris Makrantonakis, Georgios Pentheroudakis, Athanasios Athanasiadis, Helen Stergiou, Elli-Sofia Tripodaki, Alexandros Bokas, Anastasios Grivas, Eleni Timotheadou, Evangelos Bournakis, Ioannis Varthalitis, Ioannis Boukovinas
Publikováno v:
Cancers, Vol 12, Iss 7, p 1907 (2020)
Background: Cancer patients are at high risk for cancer-associated thrombosis (CAT). CAT is the second leading cause of death in these patients but it can be preventable with thromboprophylaxis. Patients and Methods: An observational, prospective, mu
Externí odkaz:
https://doaj.org/article/984588655c0345b796dd7a6149f69d24
Autor:
Nikolaos Ziras, C. Kalofonos, Christos N. Papandreou, Pavlos Papakotoulas, Ioannis Boukovinas, Georgios Koumakis, Georgios Samelis, Helen Stergiou, Eleni Timotheadou, Evangelos Bournakis, Athina Christopoulou, Georgios Papatsimpas, Athanasios Athanasiadis, Gerasimos Aravantinos, Alexandros Bokas, Alexandros Ardavanis, Paris Makrantonakis, Ioannis Varthalitis, Maria Souggleri, Pavlos Papakostas, Epameinondas Samantas, Charalambos Andreadis, Nikolaos Tsoukalas, Anastasios Grivas, Sofia Tripodaki, Georgios Pentheroudakis
Publikováno v:
Anticancer Research. 40:305-313
Background Cancer-associated thrombosis (CAT), the second leading cause of death in patients with cancer can be treated with low molecular weight heparin (LMWH) according to guidelines. Patients and methods A multicenter prospective observational stu
Autor:
Athina Christopoulou, Alexandros Ardavanis, Christos Papandreou, Georgios Koumakis, Georgios Papatsimpas, Pavlos Papakotoulas, Nikolaos Tsoukalas, Charalambos Andreadis, Georgios Samelis, Pavlos Papakostas, Gerasimos Aravantinos, Nikolaos Ziras, Maria Souggleri, Charalambos Kalofonos, Epameinondas Samantas, Paris Makrantonakis, Georgios Pentheroudakis, Athanasios Athanasiadis, Helen Stergiou, Alexandros Bokas, Anastasios Grivas, Elli-Sofia Tripodaki, Ioannis Varthalitis, Eleni Timotheadou, Ioannis Boukovinas
Publikováno v:
Oncology letters. 23(4)
Thromboprophylaxis, as a preventive measure for cancer-associated thrombosis (CAT), may be beneficial for patients with active cancer and high-risk for thrombosis. The present post hoc analysis include a total of 407 patients enrolled in the Greek Ma
Real-World Data on Thromboprophylaxis in Active Cancer Patients: Where Are We? Are We Getting There?
Autor:
Evangelos Bournakis, Athanasios Athanasiadis, Epameinondas Samantas, Gerasimos Aravantinos, Christos N. Papandreou, Georgios Samelis, Charalambos Andreadis, Maria Souggleri, Anastasios Grivas, Elli-Sofia Tripodaki, Georgios Koumakis, Nikolaos Ziras, Helen Stergiou, Eleni Timotheadou, Nikolaos Tsoukalas, Georgios Papatsimpas, Ioannis Varthalitis, Paris Makrantonakis, Alexandros Bokas, C. Kalofonos, Ioannis Boukovinas, Alexandros Ardavanis, Pavlos Papakostas, P. Papakotoulas, Athina Christopoulou, Georgios Pentheroudakis
Publikováno v:
Cancers, Vol 12, Iss 1907, p 1907 (2020)
Cancers
Volume 12
Issue 7
Cancers
Volume 12
Issue 7
Background: Cancer patients are at high risk for cancer-associated thrombosis (CAT). CAT is the second leading cause of death in these patients but it can be preventable with thromboprophylaxis. Patients and Methods: An observational, prospective, mu